Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal recessive malignant osteopetrosis in which the cause of the disease is a mutation in the SNX10 gene.
Features include always present findings: Osteopetrosis and Damage to the optic nerve (optic atrophy); and very common findings: Visual loss and Low red blood cell count (anemia). 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 3 | Feeding difficulties, Enlarged liver (hepatomegaly), Enlarged spleen (splenomegaly) |
SNX10 function has not been fully characterized.
Autosomal recessive osteopetrosis 8 is caused by mutations in the SNX10 gene on chromosome 7.
Genetic testing for SNX10 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autosomal recessive osteopetrosis 8 has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 2 very common features, 4 common features.
No clinical trials have been registered for autosomal recessive osteopetrosis 8.
8 publications have been identified in PubMed for autosomal recessive osteopetrosis 8. Research spans Case Report / Case Series (50%), Basic Science / Preclinical (38%), and Diagnostic / Biomarker (13%).
Bilici ME (2025). [PMID: 40668134](https://pubmed.ncbi.nlm.nih.gov/40668134/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Ackah SA (2025). [PMID: 41277893](https://pubmed.ncbi.nlm.nih.gov/41277893/). *Bone Rep*. [Diagnostic / Biomarker]
Whitlock JM (2025). [PMID: 40964326](https://pubmed.ncbi.nlm.nih.gov/40964326/). *bioRxiv*. [Basic Science / Preclinical]
Liu M (2025). [PMID: 39994654](https://pubmed.ncbi.nlm.nih.gov/39994654/). *BMC Med Genomics*. [Case Report / Case Series]
Reuven N (2025). [PMID: 41408708](https://pubmed.ncbi.nlm.nih.gov/41408708/). *J Bone Miner Res*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 1:11 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Blood and immune system |
3 |
Low red blood cell count (anemia), Low platelet count (thrombocytopenia), Enlarged spleen (splenomegaly) |
Head and neck | 2 | Facial palsy, Macrocephaly |
Growth and development | 1 | Failure to thrive |
Bones and joints | 1 | Osteopetrosis |
Eyes | 1 | Damage to the optic nerve (optic atrophy) |
Muscles | 1 | Damage to the optic nerve (optic atrophy) |
Sandal S (2024). [PMID: 39359949](https://pubmed.ncbi.nlm.nih.gov/39359949/). *Mol Syndromol*. [Case Report / Case Series]
Barnea-Zohar M (2024). [PMID: 39095084](https://pubmed.ncbi.nlm.nih.gov/39095084/). *J Bone Miner Res*. [Basic Science / Preclinical]